VEGF, substance P and stress, new aspects: A revisited study

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 3, 2010, Pages 229-237

  Castellani, M L ^a   Galzio, R J ^b   Felaco, P ^a   Tripodi, D ^a   Toniato, E ^a   De Lutiis, M A ^a   Conti, F ^a   Fulcheri, M ^a   Conti, C ^a   Theoharides, T C ^c   Caraffa, A ^d   Antinolfi, P ^d   Felaco, M ^a   Tete S ^a   Pandolfi, F ^e   Shaik Dasthagirisaheb, Y B ^f  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PERUGIA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory cells; Mast cells; Neuropeptides; Substance P

Indexed keywords

INTERLEUKIN 33; SUBSTANCE P; VASCULOTROPIN; CYTOKINE; VASCULOTROPIN A;

HUMAN; INFLAMMATORY CELL; MAST CELL; NONHUMAN; REVIEW; STRESS; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; MENTAL STRESS; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; CYTOKINES; HUMANS; MAST CELLS; STRESS, PSYCHOLOGICAL; SUBSTANCE P; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957925672     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression. J Exp Med 1998; 188:1135-45. (Pubitemid 28443337)
2. 206. Mol Biol Cell 1998; 9:875-884.
3. Zuccotti GV, Trabattoni D, Morelli M, Borgonovo S, Schneider L, Clerici M. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections. J Biol Regul Homeost Agents 2009; 23:119-24.
4. Tarantino G, Conca P, Tarantino M, Di Minno MND, Grimaldi E, Chianese D, Riccio A, Scopacasa F, Capone D. Does spleen volume play a role in patients with HCV-related chronic hepatitis? Int J Immunopathol Pharmacol 2009; 22:1009-17.
5. Cencioni MT, Notturno F, Caporale CM, Creati B, Prencipe V, Battistini L, Uncini A. T cell response in acute motor axonal neuropathy. Int J Immunopathol Pharmacol 2009; 22:1043-50.
6. Liu D, Jiang LS, Dai LY. Substance P and its receptors in bone metabolism. Neuropeptides 2007; 41:271-83.
7. Saria A. Neuroimmune interactions in the airways: implications for asthma, allergy, and other inflammatory airway diseases. Brain Behav Immun 1988; 2(4):318-21.
8. Theoharides TC, Konstantinidou A. Corticotropin-releasing hormone and the blood-brain-barrier. Front Biosci 2007; 12:1615-28.
9. Theoharides TC, Spanos CP, Pang X, Alferes L, Ligris K, Letourneau R, Rozniecki JJ, Webster E, Chrousos G. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology 1995; 136:5745-50.
10. Karapanou V, Kempuraj D, Theoharides TC. Oral neuroimmune network and mast cells. Eur J Inflamm 2009; 7:1-8.
11. Katsanos GS, Anogeianaki A, Orso C, Tetè S, Salini V, Antinolfi PL, Sabatino G. Mast cells and chemokines. J Biol Regul Homeost Agents 2008; 22:145-51.
12. Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J Pharmacol Exp Ther 1999; 288:1349-56.
13. Esposito P, Gheorghe D, Kandere K, Pang X, Conally R, Jacobson S, Theoharides TC. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 2001; 888:117-27. (Pubitemid 32056268)
14. Esposito P, Chandler N, Kandere-Grzybowska K, Basu S, Jacobson S, Connolly R, Tutor D, Theoharides TC. Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 2002; 303:1061-6.
15. Di Paola R, Crisafulli C, Mazzon E, Genovese T, Paterniti I, Bramanti P, Cuzzocrea S. Effect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice. Int J Immunopathol Pharmacol 2009; 22:937-50.
16. Gibbs BF. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues. Int J Immunopathol Pharmacol 2009; 22:919-27.
17. Di Gioacchino M, Perrone A, Petrarca C, et al. Early cytokine modulation after the rapid induction phase of sublingual immunotherapy with mite monomeric allergoids. Int J Immunopathol Pharmacol 2008; 21:969-76.
18. Wilms H, Rosenstiel P, Romero-Ramos M, et al. Suppression of map kinases inhibits microglial activation and attenuates neuronal cell death induced by α-synuclein protofibrils. Int J Immunopathol Pharmacol 2009; 22:897-909.
19. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 1998; 139:403-13.
20. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC. Acute immobilization stress triggers skin mast cell degranulation via corticotropin-releasing hormone, neurotensin and substance P: A link to neurogenic skin disorders. Brain Behav Immunity 1999; 13:225-239. (Pubitemid 29450200)
21. Markert UR, Arck PC, McBey BA, Manuel J, Croy BA, Marshall JS, Chaouat G, Clark DA. Stress triggered abortions are associated with alterations of granulated cells into the decidua. Am J Reprod Immunol 1997; 37:94-100.
22. Benucci M, Li Gobbi F, Sabadini L, Saviola G, Baiardi P, Manfredi M. The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of subcutaneous anti-TNFα treatment in Italian patients. Int J Immunopathol Pharmacol 2009; 22:1147-52.
23. Castellani ML, Conti P, Felaco M, Vecchiet J, Ciampoli C, Cerulli G, Boscolo P, Theoharides TC. Substance P Upregulates LTB(4) in Rat Adherent Macrophages from Granuloma Induced by KMnO(4). Neurotox Res 2009; 15:49-56.
24. Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C. TNFα and its receptors in psoriatic skin, before and after treatment with Etanercept. Int J Immunopathol Pharmacol 2009; 22:961-66.
25. Kanbe N, Kurosawa M, Nagata H, Saitoh H, Miyachi Y. Cord blood-derived human cultured mast cells produce transforming growth factor beta 1. Clin Exp Allergy 1999; 29:105-13.
26. Di Lorenzo G, Mansueto P, Pacor ML, et al. Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1077-87.
27. Murdaca G, Colombo BM, Puppo F. Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 2009; 22:557-65.
28. Sessa R, Di Pietro M, Schiavoni G, et al. Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha. Int J Immunopathol Pharmacol 2009; 22:659-68.
29. Zampetti A, Mastrofrancesco A, Flori E, Maresca V, Picardo M, Amerio P, Feliciani C. Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis. Int J Immunopathol Pharmacol 2009; 22:1067-75.
30. Kroegler B, Di Muzio G, Giovannangeli F, De Mattia M, Perricone C, Perricone R. Behçet's disease and etanercept: eighty weeks of experience. Eur J Inflamm 2009; 7:117-21.
31. Galliera E, Locati M, Mantovani A, Corsi MM. Chemokine system: new inflammatory markers on the horizon. Eur J Inflamm 2010; 8:1-6.
32. Ciprandi G, Fenoglio D, Ferrera F, De Amici M, Marseglia G. ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy. Eur J Inflamm 2010; 8:31-35.
33. Rittner HL, Brack A, Stein C. Pain and the immune system. Br J Anaesth 2008; 101:40-4.
34. Galli SJ, Tsai M. Mast cells in allergy and infection: Versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol 2010; 40:1843-51.
35. Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, Melendez AJ, McInnes IB. Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010; 184:3336-40.
36. Yip KH, Huang Y, Waye MM, Lau HY. Induction of nitric oxide synthases in primary human cultured mast cells by IgE and proinflammatory cytokines. Int Immunopharmacol 2008; 8:764-8.
37. de Mast Q, van Dongen-Lases EC, Swinkels DW, et al. Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol 2009; 145:657-64.
38. Theoharides TC. Mast cells and pancreatic cancer. N Engl J Med 2008; 358:1860-1.
39. Katayama I, Otoyama K, Yokozeki H, Nishioka K. Effect of mast cell modulators on IgE-mediated murine biphasic cutaneous reactions. Int Arch Allergy Immunol. 1996; 109:390-7. (Pubitemid 26082848)
40. Iida M, Matsumoto K, Tomita H, et al. Selective down-regulation of high-affinity IgE receptor (FcepsilonRI) alpha-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood 2001; 97:1016-22.
41. Di Bonito P, Grasso F, Mangino G, et al. Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells. Int J Immunopathol Pharmacol 2009; 22:967-8.
42. Nishimura Y, Maeda M, Kumagai N, Hayashi H, Miura Y, Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol 2009; 22:879-88.
43. Li Q, Kobayashi M, Wakayama Y, et al. Effect of phytoncide from trees on human natural killer cell function. Int J Immunopathol Pharmacol 2009; 22:951-9.
44. Chiba Y, Sato S, Misawa M. GGTI-2133, an inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma. Int J Immunopathol Pharmacol 2009; 22:929-35.
45. Ciprandi G, De Amici M, Tosca MA, Pistorio A, Marseglia GL. Sublingual immunotherapy affects specific antibody and TGF-β serum levels in patients with allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1089-96.
46. Castellani ML, Anogeianaki A, Felaco P, et al. IL-34 a newly discovered cytokine. Eur J Inflamm 2010; 8:63-66
47. Artuc M, Hermes B, Steckelings UM, Grützkau A, Henz BM. Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders? Exp Dermatol 1999; 8:1-16.
48. Kovarova M, Latour AM, Chason KD, Tilley SL, Koller BH. Human embryonic stem cells: a source of mast cells for the study of allergic and inflammatory diseases. Blood 2010; 115:3695-703.
49. Castellani ML, Felaco M, Pandolfi F, et al. Mast cells and arachidonic acid cascade in inflammation. Eur J Inflamm 2010; 8:131-7.
50. Marasini B, Conciato L, Belloli L, Massarotti M. Systemic sclerosis and cancer. Int J Immunopathol Pharmacol 2009; 22:573-8.
51. Shuvy M, BenYa'acov A, Zolotarov L, Lotan C, Ilan Y. Beta glycosphingolipids suppress rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification. Int J Immunopathol Pharmacol 2009; 22:911-18.
52. Castellani ML, Anogeianaki A, Toniato E, et al. Inter-relationship between chemokines and mast cells. Eur J Inflamm 2010; 8:7-14.
53. Zhang G-H, Liu Y-F, Hu H-Y. Preparation and cytotoxicity effect of anti-hepatocellular carcinoma SCFV immunoliposome on hepatocarcinoma cell in vitro. Eur J Inflamm 2010; 8:75-82.
54. Calabrò P, Riegler L, Limongelli G, Maddaloni V, Marione F, Golia E, D'Alessandro R, Pacileo G, Russo MG, Golino P, Calabrò R. Production of serum amyloid A in response to inflammatory cytokines by human adipocytes. Eur J Inflamm 2010; 8:99-105.
55. De Moreno De Leblanc A, Chaves S, Perdigon G. Effect of yoghurt on the cytokine profile using a murine model of intestinal inflammation. Eur J Inflamm 2009;7:97-110.
56. Germi L, Lazzaro M, Veller-Fornasa C. Therapy of oral lichen planus with monochromatic excimer light. Eur J Inflamm 2009;7:111-5.
57. Di Leo E, Aloia AM, Nettis E, Cardinale F, Foti C, Distaso M, Ferrannini A, Vacca A. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs. Int J Immunopathol Pharmacol 2009; 22:1131-4.
58. Santos J, Yang PC, Söderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48:630-6.
59. Ben-Eliyahu S, Yirmiya R, Liebeskind JC, Taylor AN, Gale RP. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun 1991; 5:193-205.
60. Palesh O, Butler LD, Koopman C, Giese-Davis J, Carlson R, Spiegel D. Stress history and breast cancer recurrence. J Psychosom Res 2007; 63:233-9.
61. Leeman SE. Diversity of neuropathogenic mechanisms and implications for neuromediation of diseases. Ann N Y Acad Sci. 2008; 1144:113-5.
62. Theoharides TC, Zhang B, Kempuraj D, et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci USA 2010; 107:4448-53.
63. Karagiannides I, Kokkotou E, Tansky M, Tchkonia T, Giorgadze N, O'Brien M, Leeman SE, Kirkland JL, Pothoulakis C. Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc Natl Acad Sci USA 2006; 103:5207-12.
64. Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 2008; 8:460-71.
65. Colina M, Ciancio G, Garavini R, Conti M, Trotta F, Covoni M. Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis. Int J Immunopathol Pharmacol 2009; 22:1125-9.
66. Young HS, Summers AM, Bhushan M, Brenchley PE, Griffiths CE. Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 2004; 122:209-15. (Pubitemid 38114658)
67. Frati F, Scurati S, Puccinelli P, et al. Inflammation in respiratory allergy treated by sublingual immunotherapy. Eur J Inflamm 2010; 8:121-9.
68. Sadeghi Koupaei MT, Ahangari G, Samanguiei Sh. Inflammatory mediator serotonin receptor gene (5-HTR3A) expression changes on human peripheral blood lymphocytes in rheumatoid arthritis. Eur J Inflamm 2010; 8:83-88.
69. Fábián TK, Gótai L, Beck A, Fábián G, Fejérdy P. The role of molecular chaperones (HSPAs/HSP70s) in oral health and oral inflammatory diseases: a review. Eur J Inflamm 2009; 7:53-61.
70. Borazan A, Camsari T, Cavdar Z, et al. The effects of darbepoetin on peritoneal fibrosis induced by chemical peritonitis and on peritoneal tissue MMP-2 and TIMP-2 levels in rats. Eur J Inflamm 2009; 7:87-96.
71. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 1999; 141:1054-60.
72. Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 2005; 116:531-6. (Pubitemid 41267124)
73. Lima DS, Zárate-Bladés CR, Souza PRM, et al. No evidence of pathological autoimmunity following Mycobacterium leprae heat-shock protein 65-DNA vaccination in mice. Eur J Inflamm 2009; 7:77-86.
74. Mennini T, Giordano L, Mengozzi M, et al. Increased IL-8 levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Inflamm 2009; 7:39-44.
75. Riccio A, Morelli G, Sangiolo MG, Morante R, Esposito C, Tarantino G. A lupus hepatitis case and its association with Ig antibodies against cytomegalovirus, herpes simplex and herpes zoster viruses. Eur J Inflamm 2009; 7:45-8.
76. Sodin-Semrl S, Antico G, Mikus R, Lakota K, Varga J, Fiore S. Lipoxin A and serum amyloid A differentially modulate phospholipase D in human fibroblast-like synoviocytes. Eur J Inflamm 2009; 7:9-18.
77. Lee KY, Lee KS, Park SJ, Kim SR, Min KH, Choe YH, Lee YC. Clinical significance of plasma and serum vascular endothelial growth factor in asthma. J Asthma 2008; 45:735-9.
78. Indinnimeo L, Bertuola F, Cutrera R, et al. Clinical evaluation and treatment of acute asthma exacerbations in children. Int J Immunopathol Pharmacol 2009; 22:867-78.
79. Amedei A, Delia Bella C, Niccolai E, Stanflin N, Benagiano M, Duranti R, Del Prete G, Murphy TF, D'Elios MM. Moraxella catarrhalis-specific TH1 cells in BAL fluids of chronic obstructive pulmonary disease patients. Int J Immunopathol Pharmacol 2009; 22:979-90.
80. Lawnicka H, Kowalewicz-Kulbat M, Sicinska P, Altmann KH, Hofmann T, Stepien H. Resorcylic acid lactone L-783,277 inhibits the growth of the human adrenal cancer cell line H295R in vitro. Int J Immunopathol Pharmacol 2009; 22:889-95.
81. Di Leo E, Aloia AM, Nettis E, Cardinale F, Foti C, Distaso M, Ferrannini A, Vacca A. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs. Int J Immunopathol Pharmacol 2009; 22:1131-4.
82. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 1998; 188:1135-45.
83. Grützkau A, Krüger-Krasagakes S, Baumeister H, Schwarz C, Kögel H, Welker P, Lippert U, Henz BM, Möller A. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998; 9:875-84.
84. Guerini FR, Tinelli C, Calabrese E, Agliardi C, Zanzottera M, De Silvestri A, Franceschi M, Grimaldi LME, Nemni R, Clerici M. HLA-A*01 is associated with late onset of Alzheimer's disease in Italian patients. Int J Immunopathol Pharmacol 2009; 22:991-9.
85. Guida G, Culla B, Scirelli T, et al. Exhaled nitric oxide and nitric oxide synthase expression in Hodgkin's disease. Int J Immunopathol Pharmacol 2009; 22:1027-34.
86. Schillaci G, Rondelli F, Pirro M, Bagaglia F, Pucci G, Noya G, Mannarino E. Endothelial progenitor cells are mobilized after major laparotomic surgery in patients with cancer. Int J Immunopathol Pharmacol 2009; 22:1035-1041.
87. Meazza C, Travaglino P, Pagani S, Laarej K, Duse M, Bozzola M. Hyperimmunoglobulinaemia in babinga pygmies is present from infancy. Int J Immunopathol Pharmacol 2009; 22:1117-20.
88. Stratta P, Mesiano P, Campo A, et al. Life expectancy of women with lupus nephritis now approaches that of the general population. Int J Immunopathol Pharmacol 2009; 22:1135-41.